The hot-spot IDH1/2 mutations have been found to be hallmarks of several types of chondroid tumors and are mainly encountered in benign enchondromas (up to 87%) [7], central conventional chondrosarcomas (about 50%), and dedifferentiated chondrosarcomas [6,15]. Here, IDH1 is linked to chondrosarcoma.